Back

Cancer and cachexia : the pivotal role of IL-6 signaling

19 June 2026 (10:00 - 10:15)
Organised by: Logo
Congress Presentation Part of: Which is the best model to study cancer treatment-related cardiovascular toxicity? Cardio-Oncology CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Associate Professor Attila Kiss

Medical University of Vienna, Vienna (Austria)

3 More presentations in this session

Presentation thumbnail
Human induced pluripotent stem cell-derived cardiomyocytes (and other cells)
Doctor P. Burridge (Chicago, US)
Slides
Presentation thumbnail
Large animals
Mr C. Galan (Madrid, ES)
Slides
Presentation thumbnail
Which is the best model to study cancer treatment-related cardiovascular toxicity? - discussion

Access the full session

Session thumbnail
Which is the best model to study cancer treatment-related cardiovascular toxicity?
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Role of PTP1B/Ptpn1 and TCPTP/Ptpn2 in sepsis-induced cardiomyopathy
1 September 2025
thumbnail
Congress Presentation
Kidney disease accelerates breast cancer growth
20 June 2025
thumbnail
Webinar
Cancer associated thrombosis: have DOACs changed daily practice?
21 September 2021
thumbnail
Congress Presentation
Mechanisms of vascular inflammaging: TNF-alpha mediates endothelial CEACAM1 expression by NF-KB and beta-Catenin in a biphasic manner
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources